Green tea influence on iron overload in thalassemia intermedia patients: a randomized controlled trial.

ABSTRACT: Background: Although iron chelation therapies have been available for many years for thalassemia intermedia patients, iron accumulation remains the major cause of death. Therefore, the need for additional chelation options is in demand. This randomized controlled study aimed to understand the effects of green tea on iron balance in thalassemia intermedia patients. Methods: Using a random selection method, 141 thalassemia intermedia patients were initially screened for inclusion in this trial; only 68 patients included after applying exclusion criteria. Two equal groups were generated (n=34/group): green tea (three cups/day after meals) + usual treatment (deferasirox iron chelator and on demand blood transfusion); and control (only usual treatment). The study lasted for a peri

SUBMITTER: Al-Momen H 

PROVIDER: S-EPMC7520712 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature